Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Long-Term Debt : $0.00 Mil (As of Apr. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Proteome Therapeutics Long-Term Debt?

Advanced Proteome Therapeutics's Long-Term Debt for the quarter that ended in Apr. 2023 was $0.00 Mil.

Advanced Proteome Therapeutics's quarterly Long-Term Debt increased from Oct. 2022 ($0.22 Mil) to Jan. 2023 ($0.24 Mil) but then declined from Jan. 2023 ($0.24 Mil) to Apr. 2023 ($0.00 Mil).

Advanced Proteome Therapeutics's annual Long-Term Debt increased from Jul. 2020 ($0.15 Mil) to Jul. 2021 ($0.17 Mil) and increased from Jul. 2021 ($0.17 Mil) to Jul. 2022 ($0.23 Mil).

Advanced Proteome Therapeutics Long-Term Debt Historical Data

The historical data trend for Advanced Proteome Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Long-Term Debt Chart

Advanced Proteome Therapeutics Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Long-Term Debt

Get a 7-Day Free Trial

0.14

0.15

0.17

0.23

Advanced Proteome Therapeutics Quarterly Data
	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23
Long-Term Debt	Get a 7-Day Free Trial															0.18	0.23	0.22	0.24	-

Advanced Proteome Therapeutics (OTCPK:APTCF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Advanced Proteome Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

0E81:Germany APC.H:Canada

Address

8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2

Website

https://www.advancedproteome.com

Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Headlines

From GuruFocus

Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement

By GlobeNewswire GlobeNewswire • 08-23-2018

Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director

By GlobeNewswire GlobeNewswire • 06-06-2018